The global bioabsorbable stents market size was valued at USD 1.14 billion in 2025 and is projected to grow from USD 1.24 billion in 2026 to USD 2.43 billion by 2034, registering a CAGR of 8.76% during the forecast period from 2026 to 2034. North America dominated the bioabsorbable stents market with a market share of 39.8% in 2025.
Bioabsorbable Stents are medical devices designed to temporarily support blocked or narrowed blood vessels and gradually dissolve or get absorbed by the body over time. They are mainly used in cardiovascular procedures to restore blood flow without leaving a permanent implant. The market is driven by the growing prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and advancements in biodegradable medical technologies.
Download a Free Sample To learn more about this report,
Growing Focus on Next-Generation Bioresorbable Scaffold Technologies
The bioabsorbable stents market trends are increasingly shaped by efforts to develop safer scaffolds with improved materials, thinner struts, and better implantation performance. Bioabsorbable devices are designed to provide temporary vessel support and, unlike permanent metallic stents, gradually degrade over time. Researchers continue to evaluate whether newer designs can address earlier concerns regarding scaffold thrombosis and long-term clinical outcomes. A major pooled analysis published in JACC: Cardiovascular Interventions in January 2025 examined early and late outcomes from the ABSORB clinical trial program, highlighting continued scientific interest in understanding outcomes before and after complete scaffold bioresorption.
Rising Emphasis on Clinical Safety and Regulatory Evaluation
The bioabsorbable stents market is also strongly influenced by regulatory scrutiny and long-term safety evidence. The FDA's PMA database shows that Abbott's Absorb GT1 Bioresorbable Vascular Scaffold was approved in July 2016, but its PMA was subsequently withdrawn in May 2023. Earlier FDA communications had identified higher rates of major adverse cardiac events and device thrombosis compared with a metallic drug-eluting stent in certain follow-up data.
Growing Prevalence of Cardiovascular Diseases and Demand for Advanced Interventional Treatments
The bioabsorbable stents market growth is primarily driven by the increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive procedures to treat narrowed or blocked blood vessels. Bioabsorbable stents are designed to provide temporary vessel support and gradually degrade or become absorbed after completing their intended function, potentially avoiding the long-term presence of a permanent metallic implant. Rising ageing populations, increasing incidence of coronary artery disease, and expanding access to interventional cardiology are supporting market development. The bioabsorbable stents market growth is also fueled by ongoing advancements in biomaterials, drug-eluting technologies, and stent design aimed at improving vascular healing and patient outcomes.
Clinical Performance Concerns and Complex Regulatory Requirements
The bioabsorbable stents market faces significant restraints due to concerns regarding long-term clinical performance, including risks associated with thrombosis, restenosis, and mechanical durability. Compared with established metallic drug-eluting stents, bioabsorbable technologies require extensive clinical evidence to demonstrate safety and effectiveness across different patient populations. The bioabsorbable stents market analysis also indicates that complex manufacturing processes, high development costs, and stringent regulatory approval requirements can delay commercialization. Limited availability of specialized products and cautious adoption by healthcare providers may further restrict market penetration in certain regions.
Advancements in Biomaterials and Next-Generation Stent Technologies
Continuous innovation in biodegradable polymers, bioresorbable metals, and drug-delivery technologies is creating significant opportunities for the bioabsorbable stents market. Manufacturers are developing next-generation devices with improved radial strength, thinner structures, more predictable degradation profiles, and enhanced drug-eluting capabilities. The bioabsorbable stents market analysis highlights opportunities in personalized cardiovascular treatments, improved imaging-guided interventions, and the development of devices designed for specific vascular conditions. Increasing research into magnesium- and polymer-based bioabsorbable materials may further support technological progress. Growing investment in minimally invasive cardiovascular care is expected to create long-term opportunities for market participants.
Balancing Mechanical Performance, Safety, and Long-Term Clinical Outcomes
One of the major challenges facing the bioabsorbable stents market is achieving sufficient mechanical strength and vessel support while ensuring predictable and safe degradation. Stent performance must remain reliable during the critical healing period without causing adverse effects as the material is absorbed. The bioabsorbable stents market growth is also affected by high research and development costs, complex manufacturing requirements, limited long-term clinical data, and competition from well-established metallic drug-eluting stents. Manufacturers must continue improving device design, clinical evidence, and procedural usability. Balancing innovation, safety, affordability, and long-term clinical performance remains a key challenge for companies operating in the global bioabsorbable stents market.
Coronary Stents Dominated the Market with 72.5% Share in 2025
The coronary stents segment accounted for the largest share of the global bioabsorbable stents market at 72.5% in 2025, driven by the high prevalence of coronary artery disease and the growing adoption of advanced minimally invasive cardiovascular procedures.
Peripheral stents continue to support market growth by addressing blockages in peripheral arteries and are increasingly used in the treatment of peripheral vascular conditions.
Request Customizationto receive a tailored report.
Polymer-Based Stents Dominated the Market with 64.7% Share in 2025
The polymer-based stents segment accounted for the largest share of the global bioabsorbable stents market at 64.7% in 2025, supported by their biocompatibility, flexibility, and ability to gradually dissolve after supporting the affected blood vessel.
Metal-based stents continue to play an important role in the market due to their strength and mechanical support, while ongoing technological developments are improving their performance and bioabsorption characteristics.
Slow-Absorption Stents Dominated the Market with 61.4% Share in 2025
The slow-absorption stents segment accounted for the largest share of the global bioabsorbable stents market at 61.4% in 2025, driven by the need for extended structural support during the healing process.
Fast-absorption stents are gaining attention due to their potential to reduce the long-term presence of foreign materials in the body and support faster restoration of natural vessel function.
Coronary Artery Disease Dominated the Market with 69.2% Share in 2025
The coronary artery disease segment accounted for the largest share of the global bioabsorbable stents market at 69.2% in 2025, supported by the increasing prevalence of cardiovascular diseases and the growing demand for minimally invasive treatment options.
Peripheral artery disease also contributes significantly to market demand as bioabsorbable stents are increasingly explored for improving blood flow in affected peripheral vessels. Other applications continue to support the adoption of these advanced cardiovascular treatment solutions.
Hospitals Dominated the Market with 57.8% Share in 2025
The hospitals segment accounted for the largest share of the global bioabsorbable stents market at 57.8% in 2025, driven by the availability of advanced cardiac infrastructure, specialized healthcare professionals, and a high volume of cardiovascular procedures.
Cardiac centers continue to play an important role due to their specialized expertise in cardiovascular treatment. Ambulatory surgical centers are gaining traction as healthcare systems increasingly adopt efficient outpatient procedures and minimally invasive treatment approaches.
Speak to an Analystto discuss market opportunities.
North America dominated the bioabsorbable stents market with a 39.8% share, valued at USD 0.45 billion in 2025. The region's leadership is driven by the high prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, strong healthcare infrastructure, and growing investments in advanced medical technologies. Rising demand for innovative coronary intervention solutions and continuous research in bioresorbable materials continue to support regional market growth.
The United States market accounted for the largest share of the North American market in 2025. Growth is driven by increasing prevalence of coronary artery disease, rising adoption of minimally invasive cardiovascular procedures, growing investments in advanced medical devices, and strong demand for innovative treatment solutions. The presence of major medical technology companies and advanced healthcare infrastructure further strengthens the country's market position.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific market accounted for 22.6% of the global bioabsorbable stents market, valued at USD 0.26 billion in 2025, and is projected to register the fastest CAGR of 10.48% during the forecast period. The market is expanding due to the growing burden of cardiovascular diseases, increasing healthcare expenditure, improving access to advanced medical treatments, and rising adoption of minimally invasive procedures. Expanding healthcare infrastructure and growing investments in medical technology continue to support regional market growth.
Japan market is witnessing steady market growth due to its advanced healthcare system, increasing adoption of innovative cardiovascular technologies, growing demand for minimally invasive procedures, and continuous investments in medical device research and development.
China market accounted for the largest share of the Asia Pacific market in 2025. Growth is supported by the rising prevalence of cardiovascular diseases, increasing healthcare expenditure, expanding hospital infrastructure, growing adoption of advanced medical devices, and rising demand for minimally invasive treatment solutions.
Canada market is witnessing steady market growth due to increasing awareness of cardiovascular health, rising adoption of minimally invasive treatment procedures, expanding access to advanced medical technologies, and growing investments in modern healthcare infrastructure.
Europe market accounted for 28.4% of the global bioabsorbable stents market, reaching USD 0.32 billion in 2025. Market growth is supported by increasing demand for advanced cardiovascular treatments, growing adoption of minimally invasive procedures, rising healthcare expenditure, and continuous innovation in bioresorbable medical device technologies. Strong focus on improving cardiovascular care and patient outcomes continues to support regional demand.
The United Kingdom market is witnessing steady market growth owing to increasing prevalence of cardiovascular disorders, growing adoption of minimally invasive cardiac procedures, rising investments in advanced healthcare technologies, and increasing demand for innovative stent solutions.
Germany market represents one of the largest markets in Europe, driven by its advanced healthcare infrastructure, increasing adoption of innovative cardiovascular devices, growing demand for minimally invasive procedures, and strong investments in medical technology research and development.
The Middle East & Africa market represented 4.1% of the global bioabsorbable stents market, totaling USD 0.05 billion in 2025. Rising healthcare investments, increasing prevalence of cardiovascular conditions, expanding access to advanced treatment technologies, and growing demand for minimally invasive procedures are supporting regional market growth.
The UAE market is a key market in the Middle East, driven by increasing investments in advanced healthcare infrastructure, growing adoption of innovative cardiovascular technologies, rising medical tourism, and expanding access to specialized cardiac treatment solutions.
Africa market is witnessing gradual market growth, supported by increasing investments in healthcare infrastructure, rising awareness of cardiovascular diseases, expanding access to specialized cardiac care, and growing adoption of advanced medical technologies. Countries such as South Africa, Kenya, and Nigeria are creating long-term growth opportunities for market participants.
The global bioabsorbable stents market is moderately competitive, with established medical device companies and specialized cardiovascular technology developers competing across polymer-based and metal-based bioresorbable stents. The key players in the industry are Abbott, Boston Scientific Corporation, Biotronik SE & Co. KG, Elixir Medical Corporation, Medtronic plc, Terumo Corporation, Reva Medical, LLC, Amaranth Medical, Inc., Arterial Remodeling Technologies, Kyoto Medical Planning Co., Ltd., Lepu Medical Technology, Lifetech Scientific Corporation, Meril Life Sciences Pvt. Ltd., ICON Interventional Systems, OrbusNeich Medical, and others. The market is driven by product innovation, clinical evidence, regulatory approvals, and the development of scaffolds with improved radial strength, controlled degradation, and long-term safety.
Industry participants are increasingly focusing on next-generation polymer and magnesium-based bioresorbable technologies to address limitations associated with earlier products. Companies are also investing in clinical trials, advanced imaging integration, strategic partnerships, and expansion into emerging markets to strengthen their competitive position.
Biotronik: A Leading Market Player
Biotronik is a prominent player in the bioabsorbable stents market, with a strong focus on magnesium-based bioresorbable scaffold technology. The company has differentiated itself through the development of the DREAMS platform, designed to provide vessel support while gradually being absorbed by the body. Its technology focus on metal-like handling and predictable resorption supports its competitive position in the market.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Single-Use Bronchoscopes Market Size, Share, Growth, Analysis, 2034
Fluoroscopy Equipment Market Size, Share, Growth, Analysis, 2034
Medical Gloves Market Size, Share, Growth, Analysis, Report, 2034
Radiology Positioning Aids Market Size, Share, Growth, 2034
Europe Diabetes Devices Market Size & Trends by 2034
Asia Pacific Diabetes Devices Market Size & Trends by 2034
We are featured on:
sales@straitsresearch.com